Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans
Ikusi/ Ireki
Data
2023-02Egilea
Canales, Ángeles
Sastre, Javier
Orduña, José María
Spruit, Cindy M.
Pérez Castells, Javier
Domínguez, Gema
Bouwman, Kim M.
van der Woude, Roosmarijn
Cañada Vicinay, Francisco Javier
Nycholat, Corwin M.
Paulson, James C.
Boons, Geert-Jan
de Vries, Robert P.
JACS Au 3(3) : 868-878 (2023)
Laburpena
Influenza virus infection remains a threat to human health since viral hemagglutinins are constantly drifting, escaping infection and vaccine-induced antibody responses. Viral hemag-glutinins from different viruses display variability in glycan recognition. In this context, recent H3N2 viruses have specificity for alpha 2,6 sialylated branched N-glycans with at least three N- acetyllactosamine units (tri-LacNAc). In this work, we combined glycan arrays and tissue binding analyses with nuclear magnetic resonance experiments to characterize the glycan specificity of a family of H1 variants, including the one responsible for the 2009 pandemic outbreak. We also analyzed one engineered H6N1 mutant to understand if the preference for tri-LacNAc motifs could be a general trend in human-type receptor-adapted viruses. In addition, we developed a new NMR approach to perform competition experiments between glycans with similar compositions and different lengths. Our results point out that pandemic H1 viruses differ from previous seasonal H1 viruses by a strict preference for a minimum of di-LacNAc structural motifs.